BrightSpring Q3 revenue up 29% to $2.9B; raises full-year guidance

BrightSpring Health Services, Inc.

2024-Q3 EPS reported -$0.18 revenue$8,213,671,000

Revenue $2,907M (+28.8% YoY); net loss narrowed to $9.0M from $130.1M.
Adjusted EBITDA $151M (+15.7%); Pharmacy Solutions revenue +35% to $2,266M.
Provider Services revenue $641M (+10% YoY).
Full-year 2024 guidance raised: Revenue $11.0-11.3B, Adj EBITDA $580-585M.
CEO cites broad-based strength across Pharmacy and Provider Services.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.